Trevaclyn 2 000 mg/ 40 mg приложен едновременно със симвастатин в сравнение със самостоятелното приложение на симвастатин или Trevaclyn 2 000 mg/ 40 mg за 12 седмици значително понижава LDL- C (- 47, 9%, - 37, 0%, - 17, 0%), TG (съответно - 33, 3%, - 14, 7%, - 21, 6%), apo B (съответно - 41, 0%, - 28, 8%, - 17, 1%), и TC (съответно - 29, 6%, - 24, 9%, - 9, 1%), както и LDL- C:
Koos simvastatiiniga 12 nädala jooksul manustatud Trevaclyn 2000 mg/ 40 mg toimel ilmnes LDL- kolesterooli (vastavalt - 47, 9%, - 37, 0%, - 17, 0%), triglütseriidide (vastavalt - 33, 3%, - 14, 7%, - 21, 6%), apo B (vastavalt - 41, 0%, - 28, 8%, - 17, 1%) ja üldkolesterooli (vastavalt - 29, 6%, - 24, 9%, - 9, 1%), samuti LDL- kolesterooli: HDL- kolesterooli (vastavalt - 57, 1%, - 39, 8%, - 31, 2%), mitte- HDL- kolesterooli (vastavalt - 45, 8%, - 33, 4%, - 18, 1%) ja üldkolesterooli: HDL- kolesterooli oluline langus (vastavalt - 43, 0%, - 28, 0%, - 24, 9%) ning HDL- kolesterooli sisalduse oluline